Xlife Sciences AG (XLS) — Cash Flow-to-Debt Ratio
Xlife Sciences AG (XLS) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2025, meaning its operating cash flow of CHF-803.62K could theoretically repay 0% of its total liabilities (CHF232.84 Million) in one year. See XLS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xlife Sciences AG Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Xlife Sciences AG across 7 annual periods. For the full cash flow conversion analysis, see XLS cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Xlife Sciences AG (2019–2025)
Year-by-year debt coverage analysis for Xlife Sciences AG. Check Xlife Sciences AG (XLS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | CHF-903.00K | CHF144.76 Million | ▼ -247.9% |
| 2024 | 0.00x | CHF-421.51K | CHF235.11 Million | ▼ -354.5% |
| 2023 | 0.00x | CHF171.78K | CHF243.82 Million | ▲ +103.9% |
| 2022 | -0.02x | CHF-4.61 Million | CHF255.00 Million | ▼ -12.3% |
| 2021 | -0.02x | CHF-4.32 Million | CHF268.83 Million | ▼ -122.4% |
| 2020 | -0.01x | CHF-401.55K | CHF55.51 Million | ▼ -2.9% |
| 2019 | -0.01x | CHF-398.24K | CHF56.64 Million | — |